Multi‐Stimuli‐Responsive Polymeric Prodrug for Enhanced Cancer Treatment
Source abstract
Abstract
Abstract Accomplishing efficient delivery of a nanomedicine to the tumor site will encounter two contradictions as follows: 1) a contradiction between prolonged circulation time and endocytosis by cancer cells; 2) a dilemma between the stability of nanomedicine during blood circulation and intracellular drug release. While developing a nanomedicine which can solve the above two contradictions simultaneously is still a challenge, here, a multi‐stimuli‐responsive polymeric prodrug (PLys‐co‐(PLys‐DA)‐co‐(PLys‐SS‐PTX))‐b‐PLGLAG‐mPEG (P‐PEP‐SS‐PTX‐DA) is synthesized which is multi‐sensitive to overexpressed matrix metalloproteinase‐2 (MMP‐2), low pH, and high concentration of glutathione in tumors. The P‐PEP‐SS‐PTX‐DA can be dePEGylated and reversed from negative at normal physiological pH to positive charge at tumor extracellular microenvironment; in this way, it can solve the contradiction between prolonged circulation time and endocytosis by cancer cells. Owing to the high reductive conditions in cancer cells, P‐PEP‐SS‐PTX‐DA is ruptured to release paclitaxel (PTX) intracellular efficiently; therefore, it can resolve the dilemma between the stability of nanomedicine during blood circulation and intracellular drug release. These indicate that the multi‐stimuli‐responsive polymeric prodrug has potential application prospects in drug delivery and cancer therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Polymer Ecomaterials Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 P. R. China
University of Chinese Academy of Sciences Beijing 100049 P. R. China
The University of Kitakyushu Department of Chemistry and Biochemistry 1‐1, Hibikino, Wakamatsu‐ku Kitakyushu 808‐0135 Fukuoka Japan
Funding
National Natural Science Foundation of China · People's Government of Jilin Province · Ministry of Science and Technology of the People's Republic of China
References (30)
Show source-provided references
1. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
2. 10.1002/adma.20180392610.1002/adma.201803926 ↗
3. 10.1007/s11426-018-9269-610.1007/s11426-018-9269-6 ↗
4. Ye M. · Adv. Mater. · 2017 · 29
5. 10.1007/s11426-018-9268-y10.1007/s11426-018-9268-y ↗
6. 10.3389/fbioe.2018.0011010.3389/fbioe.2018.00110 ↗
7. 10.1007/s40843-018-9242-310.1007/s40843-018-9242-3 ↗
8. 10.1002/adma.20140155410.1002/adma.201401554 ↗
9. 10.1002/adma.20160662810.1002/adma.201606628 ↗
10. 10.1002/adma.20170117010.1002/adma.201701170 ↗
11. 10.1021/acsami.8b0178810.1021/acsami.8b01788 ↗
12. 10.1016/j.jconrel.2018.11.01410.1016/j.jconrel.2018.11.014 ↗
13. 10.1021/acsami.8b1509810.1021/acsami.8b15098 ↗
14. Gong H.‐Y. · Chin. J. Polym. Sci. · 2019
15. 10.1039/c3cc43576h10.1039/c3cc43576h ↗
16. 10.1016/j.biomaterials.2014.01.06010.1016/j.biomaterials.2014.01.060 ↗
17. 10.1016/j.nano.2019.03.01210.1016/j.nano.2019.03.012 ↗
18. 10.1016/j.scib.2018.12.02510.1016/j.scib.2018.12.025 ↗
19. 10.1021/acsami.6b1380510.1021/acsami.6b13805 ↗
20. 10.1016/j.jconrel.2019.01.01610.1016/j.jconrel.2019.01.016 ↗
21. 10.1021/acsami.9b0201610.1021/acsami.9b02016 ↗
22. 10.1021/acsnano.8b0640010.1021/acsnano.8b06400 ↗
23. 10.1039/C9CC00519F10.1039/C9CC00519F ↗
24. 10.1021/acs.bioconjchem.8b0067110.1021/acs.bioconjchem.8b00671 ↗
25. 10.1021/acsami.7b0105610.1021/acsami.7b01056 ↗
26. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
27. 10.1016/j.jconrel.2007.08.00610.1016/j.jconrel.2007.08.006 ↗
28. 10.1016/j.jconrel.2014.09.00910.1016/j.jconrel.2014.09.009 ↗
29. 10.1021/nn300524f10.1021/nn300524f ↗
30. 10.1039/C5PY01618E10.1039/C5PY01618E ↗